Navigation Links
Jazz Pharmaceuticals to Present at Investor Conferences
Date:11/4/2008

PALO ALTO, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the company will present at three upcoming investor conferences.

On Tuesday, November 11, 2008 at 2:50 p.m. EST, Dr. Samuel R. Saks, Jazz Pharmaceuticals' CEO, will provide a corporate presentation at the Rodman & Renshaw 10th Annual Healthcare Conference in New York City.

On Wednesday, November 12, 2008 at 3:30 p.m. MST (5:30 p.m. EST), Dr. Saks will provide a corporate presentation at the Credit Suisse Healthcare Conference in Phoenix.

On Wednesday, November 19, 2008 at 11:30 a.m. EST, Robert M. Myers, President of Jazz Pharmaceuticals, will provide a corporate presentation at the Lazard Capital Markets 5th Annual Healthcare Conference in New York City.

A live webcast of these presentations may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on the site for two weeks following each presentation.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
2. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
3. MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
4. Pacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes
5. Genesis Pharmaceuticals Files Counter Claims
6. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
7. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
8. MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results
9. ISTA Pharmaceuticals Reports Third Quarter 2008 Financial Results
10. ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
11. Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: